1-20 of 24
Yves Fradet
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 3046: The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression

Camille Lafront, Lucas Germain, Gabriel H. Campolina-Silva, Cindy Weidmann, Line Berthiaume, Hélène Hovington, Hervé Brisson, Cynthia Jobin, Lilianne Frégeau-Proulx, Raul Cotau, Kevin Gonthier, Aurélie Lacouture, Patrick Caron, Claire Ménard, Chantal Atallah, Julie Riopel, Éva Latulippe, Alain Bergeron, Paul Toren, Chantal Guillemette, Martin Pelletier, Yves Fradet, Clémence Belleannée, Frédéric Pouliot, Louis Lacombe, Éric Lévesque, Étienne Audet-Walsh
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 3046.
https://doi.org/10.1158/1538-7445.AM2024-3046
Published: 22 March 2024
View articletitled, Abstract 3046: The estrogen signaling pathway reprograms prostate cancer cell metabolism and supports proliferation and disease progression
Journal Articles

Abstract 3700: Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle in prostate cancer

Kevin Gonthier, Cindy Weidmann, Line Berthiaume, Cynthia Jobin, Aurélie Lacouture, Camille Lafront, Mario Harvey, Bertrand Neveu, Jérémy Loehr, Alain Bergeron, Yves Fradet, Louis Lacombe, Julie Riopel, Éva Latulippe, Chantal Atallah, Michael Shum, Jean-Philippe Lambert, Frédéric Pouliot, Martin Pelletier, Étienne Audet-Walsh
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 3700.
https://doi.org/10.1158/1538-7445.AM2023-3700
Published: 04 April 2023
View articletitled, Abstract 3700: Isocitrate dehydrogenase 1 sustains a hybrid cytoplasmic-mitochondrial tricarboxylic acid cycle in prostate cancer
Journal Articles

Abstract A072: Serum sex steroids as prognostic biomarkers in patients receiving androgen-deprivation therapy for recurrent prostate cancer post-radiotherapy: A post hoc analysis of the PR.7 trial

Paul Toren, Azik Hoffman, Keyue Ding, France-Hélène Joncas, Frédéric Pouliot, Yves Fradet, Éric Lévesque, Chantal Guillemette, Laurence Klotz
Journal: Cancer Research
Cancer Res (2018) 78 (16_Supplement): A072.
https://doi.org/10.1158/1538-7445.PRCA2017-A072
Published: 14 August 2018
View articletitled, Abstract A072: Serum sex steroids as prognostic biomarkers in patients receiving androgen-deprivation therapy for recurrent prostate cancer post-radiotherapy: A post hoc analysis of the PR.7 trial
Journal Articles

Abstract 118: A comprehensive profile of the genomic architecture of curable prostate cancer

Michael E. Fraser, Theodorus van der Kwast, John McPherson, Colin C. Collins, Yves Fradet, Bernard Tetu, Alain Bergeron, Rob G. Bristow, Paul C. Boutros
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 118.
https://doi.org/10.1158/1538-7445.AM2016-118
Published: 15 July 2016
View articletitled, Abstract 118: A comprehensive profile of the genomic architecture of curable prostate cancer
Journal Articles

Abstract 4764: Development of a multigenic bioluminescence imaging system to detect prostate cancer cells and assess their response to therapy

Pallavi Jain, Bertrand Neveu, Yves Fradet, Frédéric Pouliot.
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4764.
https://doi.org/10.1158/1538-7445.AM2016-4764
Published: 15 July 2016
View articletitled, Abstract 4764: Development of a multigenic bioluminescence imaging system to detect prostate cancer cells and assess their response to therapy
Journal Articles

Abstract 4339: Prognostic significance of copy number alteration burden in unfavorable intermediate-risk prostate cancers harboring intraductal carcinoma and cribriform architecture

Melvin Lee Kiang Chua, Jure Murgic, Melania Pintilie, Emilie Lalonde, Charlotte Kweldam, Winnie Lo, Alejandro Berlin, Alan Dal Pra, Michele Orain, Valerie Picard, Helene Hovington, Alain Begeron, Yves Fradet, Bernard Tetu, Julie Livingstone, Alice Meng, Jun Yan Zhang, Gaetano Zafarana, Neil Fleshner, Mike Fraser, Paul Boutros, Robert Bristow, Theodorus van der Kwast
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 4339.
https://doi.org/10.1158/1538-7445.AM2016-4339
Published: 15 July 2016
View articletitled, Abstract 4339: Prognostic significance of copy number alteration burden in unfavorable intermediate-risk prostate cancers harboring intraductal carcinoma and cribriform architecture
Journal Articles

Abstract 206: Development of a molecular imaging system based on the transcriptional activity of the DD3/PCA3 non-coding RNA for imaging specifically the prostate cancer cells

Pallavi Jain, Bertrand Neveu, Yves Fradet, Frederic Pouliot
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 206.
https://doi.org/10.1158/1538-7445.AM2015-206
Published: 01 August 2015
View articletitled, Abstract 206: Development of a molecular imaging system based on the transcriptional activity of the DD3/PCA3 non-coding RNA for imaging specifically the prostate cancer cells
Journal Articles

Abstract 2966: The mutational landscape of localized gleason 6 and 7 prostate cancer

Michael E. Fraser, Veronica Y. Sabelnykova, Takafumi N. Yamaguchi, Alice Meng, Lawrence E. Heisler, Junyan Zhang, Julie Livingstone, Vincent Huang, Andre P. Masella, Fouad Yousif, Michael Xie, Nicholas J. Harding, Xihui Lin, Haiying Kong, Stephenie D. Prokopec, Alejandro Berlin, Dominique Trudel, Xuemei Luo, Timothy E. Beck, Richard de Borja, Alister D'Costa, Robert E. Denroche, Natalie S. Fox, Emilie Lalonde, Ada Wong, Taryne Chong, Michelle Sam, Jeremy Johns, Lee Timms, Nicholas Buchner, Michele Orain, Valerie Picard, Helene Hovington, Kenneth C. Chu, Christine P'ng, Bryan Lo, Francis Nguyen, Kathleen E. Houlahan, Christopher Cooper, Shaylan K. Govind, Clement Fung, Louis Lacombe, Colin C. Collins, Yves Fradet, Bernard Tetu, Theodorus van der Kwast, John McPherson, Thomas J. Hudson, Rob G. Bristow, Paul Boutros
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 2966.
https://doi.org/10.1158/1538-7445.AM2015-2966
Published: 01 August 2015
View articletitled, Abstract 2966: The mutational landscape of localized gleason 6 and 7 prostate cancer
Journal Articles

Abstract 3448: Overexpression of the steroid inactivating UGT2B28 enzyme is associated with high circulating androgens, tumor aggressiveness and adverse prostate cancer outcome

Anaïs Belledant, Hélène Hovington, Hervé Brisson, Bernard Têtu, Yves Fradet, Louis Lacombe, Patrick Caron, Chantal Guillemette, Eric Lévesque
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 3448.
https://doi.org/10.1158/1538-7445.AM2015-3448
Published: 01 August 2015
View articletitled, Abstract 3448: Overexpression of the steroid inactivating UGT2B28 enzyme is associated with high circulating androgens, tumor aggressiveness and adverse prostate cancer outcome
Journal Articles

CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy

Jemima Escamilla, Shiruyeh Schokrpur, Connie Liu, Saul J. Priceman, Diana Moughon, Ziyue Jiang, Frederic Pouliot, Clara Magyar, James L. Sung, Jingying Xu, Gang Deng, Brian L. West, Gideon Bollag, Yves Fradet, Louis Lacombe, Michael E. Jung, Jiaoti Huang, Lily Wu
Journal: Cancer Research
Cancer Res (2015) 75 (6): 950–962.
https://doi.org/10.1158/0008-5472.CAN-14-0992
Published: 12 March 2015
View articletitled, CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy
Open the PDF for CSF1 Receptor Targeting in Prostate Cancer Reverses Macrophage-Mediated Resistance to Androgen Blockade Therapy in another window
Includes: Supplementary data
Journal Articles

Abstract A16: A phase I/II clinical trial of a MUC1-glycopeptide dendritic cell vaccine in castrate resistant non-metastatic prostate cancer patients

Pierre Major, Louis Lacombe, Yves Fradet, Ronan Foley, Elizabeth Scheid, Alain Bergeron, Som Mukherjee, Olivera J. Finn, Jean Gariepy, Rafick P. Sekaly, Sebastien Hotte, Sheila Chou
Journal: Cancer Research
Cancer Res (2012) 72 (4_Supplement): A16.
https://doi.org/10.1158/1538-7445.PRCA2012-A16
Published: 09 May 2013
View articletitled, Abstract A16: A phase I/II clinical trial of a MUC1-glycopeptide dendritic cell vaccine in castrate resistant non-metastatic prostate cancer patients
Journal Articles

Abstract 2815: Urine TMPRSS2:ERG for prostate cancer risk stratification in men with elevated serum PSA

Scott A. Tomlins, Sheila Aubin, Javed Siddiqui, Robert Lonigro, Laurie Sefton-Miller, Siobhan Miick, Sarah Williamsen, Petrea Hodge, Jessica Meinke, Amy Blase, Yvonne Penabella, John Day, Daniel R. Rhodes, Kyoko Sakamoto, Jonathan Silberstein, Yves Fradet, James B. Amberson, Stephanie Meyers, Harry Rittenhouse, John T. Wei, Jack Groskopf, Arul M. Chinnaiyan
Journal: Cancer Research
Cancer Res (2011) 71 (8_Supplement): 2815.
https://doi.org/10.1158/1538-7445.AM2011-2815
Published: 15 April 2011
View articletitled, Abstract 2815: Urine TMPRSS2:ERG for prostate cancer risk stratification in men with elevated serum PSA
Journal Articles

Abstract LB-65: A gene expression predictor of pathological node stage of urothelial bladder cancer

Steven C. Smith, Alexander Spyridon Baras, Kuan-Fu Ding, Arndt Hartmann, Yves Fradet, Christopher Moskaluk, Jae K. Lee, Dan Theodorescu
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): LB-65.
https://doi.org/10.1158/1538-7445.AM10-LB-65
Published: 15 April 2010
View articletitled, Abstract LB-65: A gene expression predictor of pathological node stage of urothelial bladder cancer
Journal Articles

Abstract #1609: Prognostic value of Survivin in patients with bladder cancer

Jose Karam, Shahrokh Shariat, Pierre Karakiewicz, Yves Fradet, Umberto Capitano, Raheela Ashfaq, Francesco Montorsi, Patrick Bastian, Matthew Nielsen, Stefan Muller, Jerome Rigaud, Lukas Heukamp, George Netto, Seth Lerner, Arthur Sagalowsky, Yair Lotan
Journal: Cancer Research
Cancer Res (2009) 69 (9_Supplement): 1609.
Published: 01 May 2009
View articletitled, Abstract #1609: Prognostic value of Survivin in patients with bladder cancer
Journal Articles

The ratio of PCA3 to PSA mRNAs in urine is a better predictor of prostate biopsy results than the absolute copy level of PCA3 mRNA alone

Steven Brentano, Craig Clark, Zephyr Fors, Eric Rasmussen, Sheila Walker, Harry Rittenhouse, Sharon Bodrug, Jeannette Mathis, Jimmykim Pham, Marie Desaulniers, Guillaume Beaudry, Camille Chypre, Lyson Piche, Yves Fradet
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 743.
Published: 01 May 2005
View articletitled, The ratio of PCA3 to PSA mRNAs in urine is a better predictor of prostate biopsy results than the absolute copy level of PCA3 mRNA alone
Journal Articles

Prostate cancer: MMP2, MMP9, MMP14, TIMP2 and disease-free survival

Dominique Trudel, Yves Fradet, François Meyer, François Harel, Bernard Têtu
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 264.
Published: 01 April 2004
View articletitled, Prostate cancer: MMP2, MMP9, MMP14, TIMP2 and disease-free survival
Journal Articles

Accelerated Induction of Bladder Cancer in Patched Heterozygous Mutant Mice

Sahar Hamed, Hélène LaRue, Hélène Hovington, Johanne Girard, Lucie Jeannotte, Eva Latulippe, Yves Fradet
Journal: Cancer Research
Cancer Res (2004) 64 (6): 1938–1942.
https://doi.org/10.1158/0008-5472.CAN-03-2031
Published: 16 March 2004
View articletitled, Accelerated Induction of Bladder Cancer in Patched Heterozygous Mutant Mice
Open the PDF for Accelerated Induction of Bladder Cancer in Patched Heterozygous Mutant Mice in another window
Journal Articles

Significance of MMP-2 Expression in Prostate Cancer: an Immunohistochemical Study

Dominique Trudel, Yves Fradet, François Meyer, François Harel, Bernard Têtu
Journal: Cancer Research
Cancer Res (2003) 63 (23): 8511–8515.
Published: 16 December 2003
View articletitled, Significance of MMP-2 Expression in Prostate Cancer: an Immunohistochemical Study
Open the PDF for Significance of MMP-2 Expression in Prostate Cancer: an Immunohistochemical Study in another window
Journal Articles

Identification of a Superficial Bladder Tumor-associated Glycoform of the Carcinoembryonic Antigen by Monoclonal Antibody 19A211

Alain Bergeron, Hélène LaRue, Yves Fradet
Journal: Cancer Research
Cancer Res (1996) 56 (4): 908–915.
Published: 01 February 1996
View articletitled, Identification of a Superficial Bladder Tumor-associated Glycoform of the Carcinoembryonic Antigen by Monoclonal Antibody 19A211
Open the PDF for Identification of a Superficial Bladder Tumor-associated Glycoform of the Carcinoembryonic Antigen by Monoclonal Antibody 19A211 in another window
Journal Articles

Antibody Drug Carrier for Immunotherapy of Superficial Bladder Cancer: Ultrastructural Studies

Etienne de Harven, Yves Fradet, John G. Connolly, Wedad Hanna, Shaomu He, Yanchun Wang, Bernard C. K. Choi, Roy McGroarty, George Bootsma, Aina Tilups, Hilary Christensen
Journal: Cancer Research
Cancer Res (1992) 52 (11): 3131–3137.
Published: 01 June 1992
View articletitled, Antibody Drug Carrier for Immunotherapy of Superficial Bladder Cancer: Ultrastructural Studies
Open the PDF for Antibody Drug Carrier for Immunotherapy of Superficial Bladder Cancer: Ultrastructural Studies in another window